Delivery Order SPE2DB22D2206-SPE2DB24FJC36
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.50 firm fixed-price delivery order is for Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of August 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,356.33 delivery order contract is for the supply of Concerta ER (extended-release) tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,242.73 delivery order contract is for the supply of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a firm fixed-price pricing type and an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,129.78 firm-fixed-price delivery order is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $37,308.06, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,037.78 Firm Fixed Price delivery order is for the supply of CONCERTA ER 27 MG tablets, a specialty medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,281.02 firm fixed-price delivery order is for the supply of 100 units of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,027.46 Firm Fixed Price Delivery Order contract is for the supply of Concerta ER 18 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,128.62 firm fixed-price delivery order is for the supply of 100 units of CONCERTA ER 54 MG TABLET, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 15, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,929.41 firm-fixed-price delivery order contract is for the supply of 36 mg Concerta ER tablets, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of July 8, 2024 and is not designated as a set-aside. AmerisourceBergen holds a...